Core A: Administrative Core

核心A：行政核心

• 批准号: 10708829
• 负责人: James Brugarolas
• 金额: $ 14.59万
• 依托单位: UT SOUTHWESTERN MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-08-01 至 2027-07-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10708829
• 关键词: Advocacy; Advocate; Automobile Driving; Award; Cancer Center; Cancer Patient; Cancer Research Project; Cancer Survivor; Caregivers; Caring; Clinic; Clinical; Common Neoplasm; Communication; Communities; Complex; Comprehensive Cancer Center; Core Facility; Country; County Hospitals; Development; Education; Event; Faculty; Faculty Recruitment; Fostering; Foundations; Funding; Future; Goals; Health Resources; Healthcare; Hospitals; Incidence; Institution; Interdisciplinary Study; Kidney; Leadership; Malignant Neoplasms; Medical center; Mission; Monitor; Office of Administrative Management; Organizational Objectives; Patient advocacy; Patients; Program Evaluation; Renal carcinoma; Reporting; Research; Research Personnel; Resource Allocation; Role; Services; Structure; Texas; Translating; Underrepresented Minority; Universities; anticancer research; cancer care; career; data management; equity, diversity, and inclusion; experience; innovation; multidisciplinary; patient population; programs; recruit; role model; sound; success; synergism; volunteer

Project Summary For reasons unknown, Texas has one of the highest incidence rates of kidney cancer in the US. UT Southwestern Medical Center (UTSW), together with its affiliates, the county hospital, Parkland Memorial Hospital (staffed by UTSW faculty), and Texas Health Resources, cares for 57% of all new kidney cancer patients in the Dallas-Fort Worth metroplex. At UTSW Simmons Comprehensive Cancer Center (SCCC), kidney cancer is the 5th most common tumor type. In 2013, the Kidney Cancer Program (KCP) was inaugurated. Recognized with a Leaders in Clinical Excellence Program Award and a finalist for the metroplex Innovation in Healthcare Award, the KCP has been a trailblazer. Directed by Dr. Brugarolas, and with the goal to promote collaborative, interdisciplinary research to translate discovery and technical innovation at UTSW, the KCP provides a foundation for the UTSW Kidney SPORE and serves as a vehicle for its integration within UTSW/SCCC. As the coordinating hub of the SPORE, the Administrative Core provides essential administrative services and organizational support to the SPORE as a whole. The Director of the Core, Dr. Brugarolas, will continue to provide overall direction and scientific leadership, promote multidisciplinary interactions, and oversee fiscal management and reporting. His scientific background, experience across the research continuum and administrative roles enable him to serve as an effective overall SPORE PI and Director of the Administrative Core. Dr. Kapur, Co-Leader of the KCP and previously SPORE PI successor, has been promoted to SPORE PI and Core A Co-Director. Dr. Conacci-Sorrell, an underrepresented minority and Co-Leader of the CEP, will also be joining the Administrative Core as Co- Director. An Executive Committee comprised of representatives from all Projects and Cores provides advice on SPORE strategic directions, departmental and administrative interactions, faculty recruitment, and resource allocation. A Patient Advocacy team representing the spectrum of the cancer experience (from current patients to cancer survivors and caregivers) is actively engaged in leading community and educational events, fundraising, and perhaps most inspiringly, volunteering at SCCC clinics to assist other patients. An Internal Advisory Board made up of institutional leaders serves as a sounding board, and an External Advisory Board of leaders in their fields with complementary expertise assists by evaluating progress and providing input on future directions. The KCP/SPORE benefits from a strong commitment from both UTSW and the SCCC with each committing $200,000 yearly to promote kidney cancer research, thereby extending the reach of the CEP and DRP programs, as well as $1,100,000 in recruitment funds. Core A will continue to fulfill its objectives through the following Aims. Aim 1: Partnering with the SCCC and UTSW to advance a program of excellence in kidney cancer. Aim 2: Serving and engaging the kidney cancer patient population. Aim 3: Furthering a state-of-the-art translational kidney cancer research program. Aim 4: Recruiting investigators through successful Developmental Research and Career Enhancement Programs. Aim 5: Supporting and leading national initiatives.

项目摘要 由于未知的原因，德克萨斯州的发病率最高，在美国。 UT西南 医疗中心（UTSW）及其分支机构，县医院，帕克兰纪念医院（由 UTSW教职员工和德克萨斯州的健康资源都在乎达拉斯 - 沃斯堡的所有新肾脏癌患者中有57％ 值得大都会。在UTSW Simmons综合癌症中心（SCCC），肾癌是第五个 常见的肿瘤类型。 2013年，肾癌计划（KCP）开幕。与领导者认可 临床卓越计划奖和KCP Metroplex Innovation in Healthcare Award的决赛入围者 一直是开拓者。由Brugarolas博士指导，目的是促进合作，跨学科 KCP的研究是为了翻译UTSW的发现和技术创新的研究，为 UTSW肾脏孢子，并作为其在UTSW/SCCC中集成的工具。作为协调枢纽 在孢子中，行政核心提供了基本的行政服务和组织支持 孢子整体。核心主任Brugarolas博士将继续提供总体方向和 科学领导力，促进多学科互动，并监督财政管理和报告。他的 科学背景，研究的经验以及行政角色使他能够服务 作为有效的整体孢子PI和行政核心主任。 KCP的共同领导者Kapur博士和 以前的孢子PI继任者已晋升为孢子PI和Core A联合导演。 Conacci-Sorrell博士， CEP的代表人数不足和共同领导者，也将加入行政核心 导演。由来自所有项目和核心的代表组成的执行委员会提供了有关的建议 孢子战略方向，部门和行政互动，教师招聘以及资源 分配。一个代表癌症经验范围的患者倡导团队（目前的患者 对于癌症幸存者和照顾者）积极参与领先的社区和教育活动， 筹款活动，也许最具启发性的是，在SCCC诊所自愿提供帮助其他患者。内部 顾问委员会由机构领导者组成 通过评估进度并提供意见的互补专业知识的领导者的领导者 未来的方向。 KCP/孢子从UTSW和SCCC的坚定承诺中受益于 每年都会承诺每年促进肾脏癌研究，从而扩大了CEP的影响力 和DRP计划，以及$ 1,100,000的招聘资金。核心A将继续通过 以下目标。 AIM 1：与SCCC和UTSW合作，推进肾脏卓越计划 癌症。 AIM 2：服务和吸引肾癌患者群体。目标3：促进最先进的 翻译肾癌研究计划。目标4：通过成功发展招募调查人员 研究和职业增强计划。目标5：支持和领导国家倡议。